Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Agile Therapeutics Inc (AGRX)

Agile Therapeutics Inc (AGRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,909
  • Shares Outstanding, K 4,542
  • Annual Sales, $ 4,100 K
  • Annual Income, $ -74,890 K
  • 60-Month Beta 1.61
  • Price/Sales 1.29
  • Price/Cash Flow N/A
  • Price/Book 2.30
Trade AGRX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -26.98
  • Most Recent Earnings -3.78 on 05/12/22
  • Next Earnings Date 07/25/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 306.65%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,261.94% on 03/23/22
  • IV Low 0.00% on 07/01/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 2,312
  • Open Int (30-Day) 6,048

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -8.00
  • Growth Rate Est. (year over year) +12,587.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6100 +4.98%
on 07/01/22
2.8199 -77.29%
on 06/28/22
-0.7296 (-53.26%)
since 06/01/22
3-Month
0.6100 +4.98%
on 07/01/22
11.1200 -94.24%
on 04/12/22
-7.6076 (-92.24%)
since 04/01/22
52-Week
0.6100 +4.98%
on 07/01/22
55.6000 -98.85%
on 07/13/21
-53.7596 (-98.82%)
since 07/01/21

Most Recent Stories

More News
Agile Therapeutics Announces Pricing of $24 Million Upsized Public Offering

PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare...

AGRX : 0.6404 (-45.03%)
Agile Therapeutics to Present at The H.C. Wainwright Global Investment Conference

PRINCETON, N.J., May 17, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that Al Altomari,...

AGRX : 0.6404 (-45.03%)
Agile Therapeutics (AGRX) Q1 2022 Earnings Call Transcript

AGRX earnings call for the period ending March 31, 2022.

AGRX : 0.6404 (-45.03%)
Agile Therapeutics Announces Findings of First-Year Post-Marketing Pharmacovigilance in ACOG Poster Presentation

PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today publicly released the...

AGRX : 0.6404 (-45.03%)
Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022

Live Conference Call and Webcast at 4:30 p.m. ET...

AGRX : 0.6404 (-45.03%)
Agile Therapeutics Announces 1-For-40 Reverse Stock Split

PRINCETON, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile”), a women's healthcare company, today announced that...

AGRX : 0.6404 (-45.03%)
Agile Therapeutics Announces First Quarter 2022 Prescription Data for Twirla®

29% increase in Twirla cycles27% increase in total prescriptions (TRx) of Twirla PRINCETON, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics,...

AGRX : 0.6404 (-45.03%)
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

ATRS and NSTG are leading our lists this morning

AGRX : 0.6404 (-45.03%)
SRRA : 54.99 (+0.04%)
ATRS : 5.59 (unch)
HALO : 44.48 (+1.09%)
GSK : 43.75 (+0.51%)
Agile Therapeutics Receives $4.7M After Selling Net Operating Loss Tax Benefits Through New Jersey Economic Development Program

PRINCETON, N.J., April 11, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the receipt of...

AGRX : 0.6404 (-45.03%)
Agile Therapeutics® Announces Poster Presentation at the 2022 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists (ACOG)

The abstract was accepted by ACOG and will be presented from May 4th – May 6th, 2022...

AGRX : 0.6404 (-45.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch...

See More

Key Turning Points

3rd Resistance Point 0.7886
2nd Resistance Point 0.7468
1st Resistance Point 0.6936
Last Price 0.6404
1st Support Level 0.5986
2nd Support Level 0.5568
3rd Support Level 0.5036

See More

52-Week High 55.6000
Fibonacci 61.8% 34.5938
Fibonacci 50% 28.1050
Fibonacci 38.2% 21.6162
Last Price 0.6404
52-Week Low 0.6100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar